Search results | lundbeck

Chelsea Therapeutics has entered into m&a with Lundbeck

Lundbeck and Chelsea Therapeutics International have entered into a definitive m&a agreement under which Lundbeck will acquire Chelsea.

Lundbeck and Lieber enter into biotech partnering for psychiatric disorders

Lundbeck is entering into a psychiatric disorders  with the Lieber Institute, which has the world’s largest collection of human brains from patients with psychiatric disorders.

Lundbeck: M&A activity 2005-2013

Lundbeck, a Denmark based big pharma company, has announced 4 M&A deals since 2005, with the lead deals being the acquisitions of Ovation Pharmaceuticals and Lifehealth.

Lundbeck: Partnering activity 2005-2013

Since 2005, Lundbeck, an international pharmaceutical company, announced over 50 partnering / licensing deals.

Lundbeck: Bravely battling brain diseases

Top 50 Pharma company Lundbeck is researching, developing and marketing medications for the treatment of brain diseases. 

Lundbeck and Otsuka form a pharma alliance for Selincro

Lundbeck has expanded its pharma alliance with Otsuka Pharmaceutical Co to include development and commercialisation of the alcohol dependence drug Selincro in Japan.

Proximagen biotech partnering with Lundbeck for protein kinase inhibitors

Proximagen Limited has entered into a preclinical biotech partnering agreement with Lundbeck, a big pharma company, to further its research program related to protein kinase inhibitors

cpbannerad300x150new1gif
strategicalliances082114jpg
epicbanner1landscapejune11jpg
RSS Feed Linked In Twitter

Latest Tweets

cpbannerad300x150new3gif
bpa14banner300x150jpg
beu14banner300x150jpg